Photocure presentation at Jefferies 2012 Global Healthcare Conference

Oslo, Norway, 14 November 2012
Photocure ASA (OSE: PHO) will today present a corporate overview at Jefferies 2012 Global Healthcare Conference in London at 12:20 pm. GMT.

Participating from the company will be Kathleen Deardorff, Chief Operating Officer, and Erik Dahl, Chief Financial Officer.

Please find the presentation enclosed.

For more information, please contact:

Photocure
CFO Erik Dahl
Tel: +47 450 55 000, e-mail: ed@photocure.com

M: Communications
Mary Clark, Amber Bielecka, Hollie Vile
Tel: +44 207920 2361, Email: photocure@mcomgroup.com

About Photocure ASA
Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company and world leader in photodynamic technology. Based on our unique proprietary Photocure Technology(TM) platform, Photocure develops and commercializes highly selective and effective solutions within disease areas with high unmet medical need, such as bladder cancer, HPV and precancerous cervical lesions, colorectal cancer and skin conditions. Our aim is to provide solutions which can improve health outcomes for patients worldwide. Photocure is listed on the Oslo Stock Exchange (OSE: PHO). Information about Photocure is available at www.photocure.com.

All trademarks mentioned in this release are protected by law and registered trademarks of Photocure ASA.

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

Subscribe

Documents & Links